News

Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...
The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...
TALLMADGE, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- 2025 study stated Mitolyn is a cellular energy support supplement that ...
People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...
Loading However, the company did not release the underlying data from ... Several companies are working to develop weight-loss pills, encouraged by estimates that sales of obesity treatments ...